Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.96
-0.23 (-3.20%)
Aug 12, 2026, 10:54 AM EDT - Market open
Aardvark Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell Reiterates $3 | Sell | Reiterates | $3 | -56.90% | Aug 12, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $6 | Hold | Maintains | $6 | -13.79% | Aug 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $6 | Hold | Reiterates | $6 | -13.79% | Jul 20, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +0.57% | May 15, 2026 |
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 15, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Downgrades $4 | Sell | Downgrades | $4 | -42.53% | May 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +546.55% | Mar 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.